bioRxiv · 10.1101/2024.08.06.606812
PAI-1 Interaction with Sortilin Related Receptor-1 is Required for Lung Fibrosis
Abstract
Plasminogen activator inhibitor-1 (PAI-1) has been previously shown to promote lung fibrosis via a mechanism that requires an intact vitronectin (VTN) binding site. In the present study, employing two distinct murine fibrosis models, we find that VTN is not required for PAI-1 to drive lung scarring. This result suggested the existence of a previously unrecognized profibrotic PAI-1-protein interaction involving the VTN-binding site for PAI-1. Using an unbiased proteomic approach, we identified sortilin related receptor 1 (SorlA) as the most highly enriched PAI-1 interactor in the fibrosing lung. We next investigated the role of SorlA in pulmonary fibrosis and found that SorlA deficiency protected against lung scarring in a murine model. We further show that, while VTN deficiency does not influence fibrogenesis in the presence or absence of PAI-1, SorlA is required for PAI-1 to promote scarring. These results, together with data showing increased SorlA levels in human IPF lung tissue, support a novel mechanism through which the potent profibrotic mediator PAI-1 drives lung fibrosis and implicate SorlA as a new therapeutic target in IPF treatment.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Sisson, T. H., Osterholzer, J. J., Leung, L., Basrur, V., Nesvizhskii, A., Subbotina, N., Warnock, M., Torrente, D., Virk, A. Q., Horowitz, J. C., Migliorini, M., Strickland, D. K., Kim, K. K., Huang, S. K., Lawrence, D. A.. 2024-08-08. PAI-1 Interaction with Sortilin Related Receptor-1 is Required for Lung Fibrosis. https://doi.org/10.1101/2024.08.06.606812
Cite the original work for its findings. Save a collection to share your selection of sources.